Platelet function in disseminated intravascular coagulation: A systematic review

Platelets

Volumn 29, Issue 3, 2018, Pages 238-248

  Laursen, Mathies Appel ^a   Larsen, Julie Brogaard ^a   Hvas, Anne Mette ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

(MeSH): disseminated intravascular coagulation; platelet function tests; platelets

Indexed keywords

DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; NONHUMAN; PLATELET COUNT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; ANIMAL; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; DISEASE MODEL; HEALTH SURVEY; META ANALYSIS; METABOLISM; THROMBOCYTE;

BIOLOGICAL MARKER;

ANIMALS; BIOMARKERS; BLOOD COAGULATION; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; POPULATION SURVEILLANCE;

EID: 85045631525     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2018.1442567     Document Type: Review

References (50)

1. Gando S, Saitoh D, Ogura H, Fujishima S, Mayumi T, Araki T, Ikeda H, Kotani J, Kushimoto S, Miki Y, et al. A multicenter, prospective validation study of the japanese association for acute medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Critical Care (London, England). 2013; 17(3): R111.
2. Gando SS, Levi M, Toh CH., Disseminated intravascular coagulation. Nature Reviews Disease Primers. 2016; 2: 16037.
3. Semeraro N, Ammollo CT, Semeraro F, Colucci M.Sepsis, thrombosis and organ dysfunction. Thrombosis Research. 2012; 129(3): 290–295.
4. Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S.Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: A meta-analysis of randomized controlled trials. J Thromb Haemost. 2016; 14(3): 518–530.
5. Wei Q, 2014. Clinical research on hematological malignancies complicated with dic - a single center report in china. Blood. 124(21).
6. Semeraro N, Ammollo CT, Semeraro F, Colucci M.Coagulopathy of acute sepsis. Seminars in Thrombosis and Hemostasis. 2015; 41(6): 650.
7. Levi M, Van Der Poll T. Coagulation and sepsis. Thrombosis Research. 2017; 149: 38–44.
8. Liaw PC, Ito T, Iba T, Thachil J, Zeerleder S.Damp and dic: the role of extracellular DNA and DNA-binding proteins in the pathogenesis of dic. Blood Rev. 2016; 30(4): 257–261.
9. Rondina MT, Carlisle M, Fraughton T, Brown SM, Miller RR, 3rd, Harris ES, Weyrich AS, Zimmerman GA, Supiano MA, Grissom CK.Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci. 2015; 70(2): 225–231.
10. Levi M, Toh CH, J T, Watson HG.Guidelines for the diagnosis and management of disseminated intravascular coagulation. British committee for standards in haematology. Br J Haematol. 2009; 145(1): 24–33.
11. Tsirigotis P, Chondropoulos S, Frantzeskaki F, Stamouli M, Gkirkas K, Bartzeliotou A, Papanikolaou N, Atta M, Papassotiriou I, Dimitriadis G, et al. Thrombocytopenia in critically ill patients with severe sepsis/septic shock: prognostic value and association with a distinct serum cytokine profile. Journal of Critical Care. 2016; 32: 9.
12. Brenner T, Schmidt K, Delang M, Mehrabi A, Bruckner T, Lichtenstern C, Martin E, Weigand MA, Hofer S.Viscoelastic and aggregometric point-of-care testing in patients with septic shock - cross-links between inflammation and haemostasis. Acta Anaesthesiologica Scandinavica. 2012; 56(10): 1277.
13. Yaguchi A, Lobo FL, Vincent JL, Pradier O.Platelet function in sepsis. Journal of Thrombosis and Haemostasis: JTH. 2004; 2(12): 2096.
14. Shannon O.Platelet interaction with bacterial toxins and secreted products. Platelets. 2015; 26(4): 302.
15. Venugopal A.Disseminated intravascular coagulation. Indian Journal of Anaesthesia. 2014; 58(5): 603.
16. Moher D, Liberati A, Tetzlaff J, Altman DG.Preferred reporting items for systematic reviews and meta-analyses: The prisma statement. PLoS Med. 2009; 6(7): e1000097.
17. Belovezhdov N, Robeva R, Genova V.Blood coagulation in glomerulonephritis. Int Urol Nephrol. 1986; 18(2): 193–203.
18. Connolly-Andersen AM, Sundberg E, Ahlm C, Hultdin J, Baudin M, Larsson J, Dunne E, Kenny D, Lindahl TL, Ramstrom S, et al. Increased thrombopoiesis and platelet activation in hantavirus-infected patients. Journal of Infectious Diseases. 2015; 212(7): 1061–1069.
19. Delabranche X, Boisrame-Helms J, Asfar P, Berger A, Mootien Y, Lavigne T, Grunebaum L, Lanza F, Gachet C, Freyssinet JM, et al. Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Intensive Care Med. 2013; 39(10): 1695–1703.
20. Kander T, Larsson A, Taune V, Schott U, Tynngard N.Assessment of haemostasis in disseminated intravascular coagulation by use of point-of-care assays and routine coagulation tests, in critically ill patients; a prospective observational study. PloS One. 2016; 11(3): e0151202.
21. Ohuchi M, Fujino K, Kishimoto T, Yamane T, Hamamoto T, Tabata T, Tsujita Y, Matsushita M, Takahashi K, Matsumura K, et al. Association of the plasma platelet-derived microparticles to platelet count ratio with hospital mortality and disseminated intravascular coagulopathy in critically ill patients. J Atheroscler Thromb. 2015; 22(8): 773–782.
22. Segura D, Monreal L, Armengou L, Tarancon I, Brugues R, Escolar G.Mean platelet component as an indicator of platelet activation in foals and adult horses. J Vet Intern Med. 2007; 21(5): 1076–1082.
23. Shimura M, Wada H, Hiyoyama K, Nakasaki T, Takagi M, Deguchi A, Mori Y, Nisikawa M, Deguchi K, Shiku H.Increased plasma soluble-adhesion molecules in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Clinical and Applied Thrombosis/Hemostasis. 1998; 4(3): 196–200.
24. Washington AV, Gibot S, Acevedo I, Gattis J, Quigley L, Feltz R, De La Mota A, Schubert RL, Gomez-Rodriguez J, Cheng J, et al. Trem-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Invest. 2009; 119(6): 1489–1501.
25. Yahara Y, Okawa S, Onozawa Y, Motomiya T, Tanoue K, Yamazaki H.Activation of platelets in cancer, especially with reference to genesis of disseminated intravascular coagulation. Thromb Res. 1983; 29(1): 27–35.
26. Yamashita Y, Naitoh K, Wada H, Ikejiri M, Mastumoto T, Ohishi K, Hosaka Y, Nishikawa M, Katayama N.Elevated plasma levels of soluble platelet glycoprotein vi (gpvi) in patients with thrombotic microangiopathy. Thrombosis Research. 2014; 133(3): 440–444.
27. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN.Plasma p-selectin is increased in thrombotic consumptive platelet disorders. Blood. 1994; 83(6): 1535–1541.
28. Hlousková D, Polívková J, Pospísil J, Kase F.A comparison of haemocoagulation tests in the experimental endotoxin model dic and in rats whole-body irradiated by 250 gy. Sborník Lékarský. 1993; 94(1): 31–38.
29. Ito T, Asai F, Oshima T, Kobayashi S.Role of activated platelets in endotoxin-induced dic in rats. Thromb Res. 1990; 59(4): 735–747.
30. Kunishima S, Kobayashi S, Naoe T.Increased but highly dispersed levels of plasma glycocalicin in patients with disseminated intravascular coagulation. Eur J Haematol. 1996; 56(3): 173–177.
31. Markwardt F, Nowak G, Glusa E, Hoffman A.The influence of drugs on disseminated intravascular coagulation (dic). Iii. Effects of busulfan-induced thrombocytopenia and inhibition of platelet function by acetylsalicylic acid. Thromb Res. 1979; 15(1–2): 79–88.
32. Moriau M, Noel H, Masure R.Effects of alpha and beta receptor stimulating and blocking agents on experimental disseminated intravascular coagulation. Thromb Diath Haemorrh. 1974; 32(1): 157–170.
33. Moriau M, Rodhain J, Noel H.Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thrombin. Thrombdiatheshaemorrh. 1974; 32(1): 171–188.
34. Zhao ZG, Niu CY, Zhang YP, Hou YL, Li JJ, Jiang H.Exogenous normal lymph alleviating kidney injury by improving coagulation function in disseminated intravascular coagulation rats. Ren Fail. 2012; 34(2): 221–226.
35. Stefanidis I, Frank D, Maurin N.Hemostasis activation markers in acute renal failure. Ren Fail. 1998; 20(1): 147–155.
36. Yamazaki H, Motomiya T, Watanabe C, Miyagawa N, Yahara Y, Okawa Y, Onozawa Y.Consumption of larger platelets with decrease in adenine nucleotide content in thrombosis, disseminated intravascular coagulation, and postoperative state. Thromb Res. 1980; 18(1–2): 77–88.
37. Vassiliou AG, Mastora Z, Orfanos SE, Jahaj E, Maniatis NA, Koutsoukou A, Armaganidis A, Kotanidou A.Elevated biomarkers of endothelial dysfunction/activation at icu admission are associated with sepsis development. Cytokine. 2014; 69(2): 240–247.
38. Kaplan KL, Owen J.Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood. 1981; 57(2): 199–202.
39. Hermida J, Montes R, Munoz MC, Orbe J, Paramo JA, Rocha E.Effects of low molecular weight heparin, alone or combined with antithrombin iii, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits. Am J Hematol. 1999; 60(1): 6–11.
40. Rasi V, Ikkala E, Valtonen V.Plasma β-thromboglobulin in severe infection. Thrombosis Research. 1982; 26(4): 267–274.
41. Di Nisio M, Thachil J, Squizzato A.Management of disseminated intravascular coagulation: A survey of the international society on thrombosis and haemostasis. Thromb Res. 2015; 136(2): 239–242.
42. Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, Machin S.Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol. 2011; 155(1): 30–44.
43. Hayward CP, Moffat KA, Pai M, Liu Y, Seecharan J, McKay H, Webert KE, Cook RJ, Heddle NM.An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thromb Haemost. 2008; 100(1): 134–145.
44. Hanke AA, Roberg K, Monaca E, Sellmann T, Weber CF, Rahe-Meyer N, Gorlinger K.Impact of platelet count on results obtained from multiple electrode platelet aggregometry (multiplate). Eur J Med Res. 2010; 15(5): 214–219.
45. Tiedemann Skipper M, Rubak P, Halfdan Larsen O, Hvas AM.Thrombocytopenia model with minimal manipulation of blood cells allowing whole blood assessment of platelet function. Platelets. 2016; 27(4): 295–300.
46. Skipper MT, Rubak P, Stentoft J, Hvas AM, Larsen OH. Evaluation of platelet function in thrombocytopenia. Platelets 2017; Apr 14:1–7 [Epub ahead of print].
47. Ono T, Mimuro J, Madoiwa S, Soejima K, Kashiwakura Y, Ishiwata A, Takano K, Ohmori T, Sakata Y.Severe secondary deficiency of von willebrand factor-cleaving protease (adamts13) in patients with sepsis-induced disseminated intravascular coagulation: Its correlation with development of renal failure. Blood. 2006; 107(2): 528–534.
48. Hyun J, Kim HK, Kim JE, Lim MG, Jung JS, Park S, Cho HI.Correlation between plasma activity of adamts-13 and coagulopathy, and prognosis in disseminated intravascular coagulation. Thromb Res. 2009; 124(1): 75–79.
49. Chinen Y, Kuroda J, Ohshiro M, Shimura Y, Mizutani S, Nagoshi H, Sasaki N, Nakayama R, Kiyota M, Yamamoto-Sugitani M, et al. Low adamts-13 activity during hemorrhagic events with disseminated intravascular coagulation. Int J Hematol. 2013; 97(4): 511–519.
50. Hayakawa M, Gando S, Hoshino H.A prospective comparative study of three sets of criteria for disseminated intravascular coagulation: ISTH criteria vs Japanese criteria. Clin Appl Thromb Hemost. 2007; 13(1): 65–72.